Madame Bioscience PCL Ratios and Metrics

Market cap in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	388	565	755	1,138	2,061	2,607
Market Cap Growth	2.65%	-25.15%	-33.63%	-44.78%	-20.94%	45.01%
Enterprise Value	539	864	1,447	1,838	2,493	2,720
Last Close Price	0.48	0.70	1.10	1.85	3.35	6.15
PE Ratio	-	12.36	-	-	-	-
PS Ratio	0.25	0.38	0.36	0.49	0.93	1.40
PB Ratio	0.48	0.71	1.39	1.46	1.73	2.94
P/TBV Ratio	1.13	1.78	3.84	2.65	3.21	3.14
P/FCF Ratio	-	-	3.57	35.16	-	-
P/OCF Ratio	314.12	14.24	3.33	15.81	-	-
EV/Sales Ratio	0.35	0.58	0.68	0.80	1.12	1.46
EV/EBITDA Ratio	-	-	13.04	-	-	-
EV/EBIT Ratio	-	-	34.19	-	-	-
EV/FCF Ratio	-13.00	-	6.84	56.78	-	-
Debt / Equity Ratio	0.27	0.31	1.13	1.06	0.77	0.37
Debt / EBITDA Ratio	-	-	4.61	-	-	-
Debt / FCF Ratio	-	-	2.90	25.32	-	-
Net Debt / Equity Ratio	0.13	0.06	0.98	1.01	0.56	0.31
Net Debt / EBITDA Ratio	-0.32	-0.43	4.81	-9.60	-2.16	-7.66
Net Debt / FCF Ratio	-2.59	-28.19	2.52	24.24	-2.17	-0.89
Asset Turnover	1.03	1.01	1.16	1.02	1.10	1.21
Inventory Turnover	17.68	12.23	9.29	7.74	6.68	5.14
Quick Ratio	1.18	1.02	0.52	0.40	0.97	0.73
Current Ratio	1.41	1.22	0.71	0.68	1.52	1.54
Return on Equity (ROE)	-20.40%	6.94%	-49.78%	-41.90%	-42.18%	-17.59%
Return on Assets (ROA)	-16.86%	-7.89%	1.45%	-4.62%	-11.92%	-4.47%
Return on Invested Capital (ROIC)	-45.43%	-17.95%	3.21%	-9.72%	-25.55%	-9.73%
Return on Capital Employed (ROCE)	-39.60%	-18.70%	5.30%	-15.10%	-20.50%	-10.60%
Earnings Yield	-41.42%	8.09%	-43.90%	-35.65%	-20.49%	-5.85%
FCF Yield	-10.70%	-0.31%	28.01%	2.84%	-14.92%	-11.69%
Buyback Yield / Dilution	-16.22%	-24.47%	-0.93%	-2.57%	-50.07%	-5.07%